Study of ultrasonographic features of lymph node in advanced stage dementia patients

Asan Medical Center0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•From the date of IRB approval until December 31, 2024, Seoul Asan Hospital is recruiting participants aged 50 and above who have been diagnosed with progressive dementia with a GDS score of 4 or higher. Participants must meet the following criteria:
•Have never been diagnosed with dementia or mild cognitive impairment.
•Have no other physical or mental disorders.
•Have no history of diagnosed lymph node diseases.
•These criteria are for recruiting a control group.

•Patients with Dementia with Lewy Bodies (DLB) are excluded. Those with severe renal function impairment (GFR 30 or below) or concomitant liver failure are also excluded. Participants who do not wish to participate or refuse to sign the consent form are excluded. Additionally, participants may be excluded if, at the discretion of the clinical trial investigator, it is deemed impractical to conduct the clinical trial due to reasons other than those mentioned above.

发起方